Extensively Drug-Resistant Mycobacterium tuberculosis from Aspirates, Rural South Africa
Scott K. Heysell

, Anthony P. Moll, Neel R. Gandhi, François J. Eksteen, Palav Babaria, Yacoob Coovadia, Lynn Roux, Umesh Lalloo, Gerald Friedland, and N. Sarita Shah
Author affiliations: Tugela Ferry Care and Research Collaboration, Tugela Ferry, South Africa (S.K. Heysell, A.P. Moll, N.R. Gandhi, F.J. Eksteen, P. Babaria, U. Lalloo, G. Friedland, N.S. Shah); University of Virginia, Charlottesville, Virginia, USA (S.K. Heysell); Philanjalo Care Center, Tugela Ferry (A.P. Moll, FJ. Eksteen); Yale University, New Haven, Connecticut, USA (P. Babaria, G. Friedland); Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA (N.R. Gandhi, N.S. Shah); National Health Laboratory Services, Durban, South Africa (Y. Coovadia, L. Roux); Enhancing Care Initiative-KZN, Nelson R. Mandela School of Medicine, Durban (U. Lalloo)
Main Article
Table 2
Comparison of culture yield for Mycobacterium tuberculosis in patients with collection of sputum and either lymph node or pleural fluid aspirate, South Africa, September 1, 2006–December 31, 2008*
Result from sputum |
Lymph node, n = 9
|
|
Pleural fluid, n = 8
|
DS TB |
XDR TB |
No DST |
No growth |
DS TB |
XDR TB |
No DST |
No growth |
DS TB |
2 |
|
|
|
|
1 |
|
|
1 |
XDR TB |
|
1 |
|
|
|
|
2 |
|
2 |
No growth |
1 |
|
2 |
3 |
|
|
2 |
|
|
Main Article
Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.